tacrine has been researched along with 2019 Novel Coronavirus Disease in 1 studies
Tacrine: A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders.
tacrine : A member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koźmiński, P | 1 |
| Niedziałek, D | 1 |
| Wieczorek, G | 1 |
| Halik, PK | 1 |
| Czarnecka, K | 1 |
| Rogut, A | 1 |
| Cheda, Ł | 1 |
| Rogulski, Z | 1 |
| Szymański, P | 1 |
| Gniazdowska, E | 1 |
1 other study available for tacrine and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
New Imaging Modality of COVID-19 Pneumonia Developed on the Basis of Alzheimer's Disease Research.
Topics: Acetylcholinesterase; Aged; Alzheimer Disease; COVID-19; Gallium Radioisotopes; Humans; Radiopharmac | 2022 |